Latest Breaking News On - Ilse dieussaert - Page 1 : comparemela.com

Risk for Preterm Birth Stops Maternal RSV Vaccine Trial

With a maternal vaccine already on the market to protect newborns from RSV, the outlook for another looked promising, but latest phase 3 trial of a new candidate is now halted over safety concerns.

New providenceNew yorkUnited statesWaals gewestIlse dieussaertAarone glattDepartment of medicineNew england journalInfectious diseasesHospital epidemiologistMount sinai south nassau

Pfizer s RSV vaccine given to mums-to-be may raise the risk of premature birth, experts warn

Experts have called for tougher scrutiny over the new Respiratory syncytial virus (RSV) jab, which could be approved in the US and UK later this year.

United statesUnited kingdomIlse dieussaertCody meissnerVirological institute of the university hospital erlangenStanding committee on vaccinationDartmouth geisel school of medicineDrug administrationUnited kingdom health security agencyUs centers for diseaseEuropean medicines agencyUs national institutes of healthVirological instituteUniversity hospital erlangenStanding committeeProfessor cody meissner

Q&A on RSV Maternal Vaccine and Antibody Candidates to Protect Infants

Q&A on RSV Maternal Vaccine and Antibody Candidates to Protect Infants
factcheck.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from factcheck.org Daily Mail and Mail on Sunday newspapers.

United statesAyden diasPhil dormitzerIona munjalIlse dieussaertWilliam schaffnerEuropean commissionAmerican academy of pediatricsNational institutes of healthProducts advisory committeeCenters for diseaseLancet child adolescent healthWorld health organizationVanderbilt university school of medicineNational foundation for infectious diseasesAdvisory committee on immunization practices